No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Title
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Authors
Keywords
Pathology, Healing, Inflammation, Treatment
Journal
GASTROENTEROLOGY
Volume 152, Issue 4, Pages 787-798.e2
Publisher
Elsevier BV
Online
2016-11-16
DOI
10.1053/j.gastro.2016.11.004

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now